Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-05-23 Sale |
2025-05-28 4:08 pm |
Emergent BioSolutions Inc. | EBS | Katkin Keith Director |
7,844 | $6.3 | $49,417 | 86,431 (Direct) |
View |
| 2025-05-13 Purchase |
2025-05-15 4:02 pm |
Emergent BioSolutions Inc. | EBS | PAPA JOSEPH C President and CEO |
60,000 | $5.83 | $349,800 | 342,500 (Direct) |
View |
| 2025-03-12 Sale |
2025-03-12 6:13 pm |
Emergent BioSolutions Inc. | EBS | Fowler Neal Franklin Director |
35,000 | $5.83 | $204,050 | 101,100 (Direct) |
View |
| 2025-03-12 Sale |
2025-03-12 6:13 pm |
Emergent BioSolutions Inc. | EBS | Zoon Kathryn C Director |
10,000 | $5.73 | $57,300 | 44,482 (Direct) |
View |
| 2025-02-12 Sale |
2025-03-04 4:08 pm |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
29,991 | $0 | $0 | 114,156 (Direct) |
View |
| 2025-02-12 Sale |
2025-03-04 4:05 pm |
Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer |
16,916 | $0 | $0 | 152,337 (Direct) |
View |
| 2024-11-12 Sale |
2024-11-14 4:18 pm |
Emergent BioSolutions Inc. | EBS | DeGolyer Donald W Director |
25,000 | $10.91 | $272,750 | 111,100 (Direct) |
View |
| 2024-11-11 Sale |
2024-11-13 4:04 pm |
Emergent BioSolutions Inc. | EBS | White Marvin L Director |
14,287 | $11.97 | $171,015 | 54,092 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-06-08 Tax Withholding |
2025-06-10 4:12 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices |
1,167 | $6.63 | 107,955 (Direct) |
View |
| 2025-06-08 Tax Withholding |
2025-06-10 4:12 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
1,249 | $6.63 | 174,927 (Direct) |
View |
| 2025-06-08 Tax Withholding |
2025-06-10 4:12 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Williams Paul Anthony SVP, Products Business |
464 | $6.63 | 85,871 (Direct) |
View |
| 2025-06-08 Tax Withholding |
2025-06-10 4:07 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer |
2,733 | $6.63 | 296,492 (Direct) |
View |
| 2025-04-30 Option Award |
2025-05-02 8:31 pm |
N/A 2032-04-29 |
Emergent BioSolutions Inc. | EBS | Richard Ronald Director |
50,227 | $0 | 147,089 (Direct) |
View |
| 2025-04-30 Option Award |
2025-05-02 8:31 pm |
N/A 2032-04-29 |
Emergent BioSolutions Inc. | EBS | White Marvin L Director |
50,227 | $0 | 130,067 (Direct) |
View |
| 2025-04-30 Option Award |
2025-05-02 8:31 pm |
N/A 2032-04-29 |
Emergent BioSolutions Inc. | EBS | Fowler Neal Franklin Director |
50,227 | $0 | 177,075 (Direct) |
View |
| 2025-04-30 Option Award |
2025-05-02 8:31 pm |
N/A 2032-04-29 |
Emergent BioSolutions Inc. | EBS | Zoon Kathryn C Director |
50,227 | $0 | 120,457 (Direct) |
View |
| 2025-04-30 Option Award |
2025-05-02 8:31 pm |
N/A 2032-04-29 |
Emergent BioSolutions Inc. | EBS | Dayal Sujata Tyagi Director |
50,227 | $0 | 139,104 (Direct) |
View |
| 2025-04-30 Option Award |
2025-05-02 8:30 pm |
N/A 2032-04-29 |
Emergent BioSolutions Inc. | EBS | Katkin Keith Director |
50,227 | $0 | 135,847 (Direct) |
View |
| 2025-04-30 Option Award |
2025-05-02 8:30 pm |
N/A 2032-04-29 |
Emergent BioSolutions Inc. | EBS | Harsanyi Zsolt Chairman |
50,227 | $0 | 165,304 (Direct) |
View |
| 2025-04-30 Option Award |
2025-05-02 8:30 pm |
N/A 2032-04-29 |
Emergent BioSolutions Inc. | EBS | DeGolyer Donald W Director |
50,227 | $0 | 187,075 (Direct) |
View |
| 2025-04-30 Option Award |
2025-05-02 8:30 pm |
N/A 2032-04-29 |
Emergent BioSolutions Inc. | EBS | SULLIVAN LOUIS W Director |
50,227 | $0 | 180,670 (Direct) |
View |
| 2025-04-07 Tax Withholding |
2025-04-09 6:36 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices |
561 | $4.44 | 109,122 (Direct) |
View |
| 2025-04-07 Tax Withholding |
2025-04-09 6:35 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
480 | $4.44 | 176,176 (Direct) |
View |
| 2025-03-06 Option Award(A) |
2025-04-09 6:31 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices |
62,500 | $0 | 109,683 (Direct) |
View |
| 2025-03-12 Option Award |
2025-03-12 6:12 pm |
2025-03-12 2031-03-12 |
Emergent BioSolutions Inc. | EBS | PAPA JOSEPH C President and CEO |
500,000 | $0 | 2,815,000 (Direct) |
View |
| 2025-03-06 Option Award |
2025-03-10 4:18 pm |
N/A 2032-03-05 |
Emergent BioSolutions Inc. | EBS | Perl Jessica SVP, General Counsel, Corp Sec |
62,500 | $0 | 164,332 (Direct) |
View |
| 2025-03-06 Option Award |
2025-03-10 4:18 pm |
N/A 2032-03-05 |
Emergent BioSolutions Inc. | EBS | Williams Paul Anthony SVP, Products Business |
62,500 | $0 | 296,449 (Direct) |
View |
| 2025-03-06 Option Award |
2025-03-10 4:18 pm |
N/A 2032-03-05 |
Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer |
325,434 | $0 | 783,715 (Direct) |
View |
| 2025-03-06 Option Award |
2025-03-10 4:17 pm |
N/A 2032-03-05 |
Emergent BioSolutions Inc. | EBS | Lowry Simon C SVP, R&D, CMO |
62,500 | $0 | 194,981 (Direct) |
View |
| 2025-03-06 Option Award |
2025-03-10 4:17 pm |
N/A 2032-03-05 |
Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices |
62,500 | $0 | 324,686 (Direct) |
View |
| 2025-03-06 Option Award |
2025-03-10 4:17 pm |
N/A 2032-03-05 |
Emergent BioSolutions Inc. | EBS | PAPA JOSEPH C President and CEO |
282,500 | $0 | 1,315,000 (Direct) |
View |
| 2025-03-06 Option Award |
2025-03-10 4:17 pm |
N/A 2032-03-05 |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
62,500 | $0 | 426,269 (Direct) |
View |
| 2025-03-05 Tax Withholding |
2025-03-07 4:39 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices |
292 | $5.8 | 47,183 (Direct) |
View |
| 2025-03-01 Tax Withholding |
2025-03-04 4:08 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
313 | $7.48 | 114,156 (Direct) |
View |
| 2025-02-28 Tax Withholding |
2025-03-04 4:06 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Williams Paul Anthony SVP, Products Business |
498 | $7.48 | 23,835 (Direct) |
View |
| 2025-02-28 Tax Withholding |
2025-03-04 4:05 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer |
1,756 | $7.48 | 152,337 (Direct) |
View |
| 2025-02-09 Tax Withholding |
2025-02-11 4:01 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Perl Jessica SVP, General Counsel, Corp Sec |
918 | $10 | 5,887 (Direct) |
View |
| 2024-12-15 Option Award |
2024-12-17 5:44 pm |
N/A 2031-12-14 |
Emergent BioSolutions Inc. | EBS | Lowry Simon C SVP, R&D, CMO |
69,981 | $0 | 69,981 (Direct) |
View |
| 2024-12-08 Tax Withholding |
2024-12-10 4:02 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
18,674 | $9.01 | 144,460 (Direct) |
View |
Ownership |
2024-11-21 4:02 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Lowry Simon C SVP, R&D, CMO |
0 | $0 | 0 (Direct) |
View |
| 2024-11-11 Tax Withholding |
2024-11-13 4:04 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices |
632 | $11.97 | 47,475 (Direct) |
View |
Ownership |
2024-11-12 4:26 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Perl Jessica SVP, General Counsel, Corp Sec |
0 | $0 | 40,250 (Direct) |
View |